Understanding how COVID-19 causes severe lung inflammation
Official title: Regulation of Pathologic Inflammasome Responses to SARS-CoV-2
Funded at Univ of North Carolina Chapel Hill · NIH-11094042 · Data updated 2026-11-12
This study is looking into how COVID-19 can lead to serious breathing problems by examining the body's inflammatory response, with the hope of finding new ways to help patients who are struggling with severe symptoms.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | May 23, 2024 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $104,722 |
| NIH project number | 5K99AI175479-02 |
| Project ID | NIH-11094042 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced severe COVID-19 symptoms, particularly those with acute respiratory distress syndrome.
✕Less likely to help
Patients with mild or asymptomatic COVID-19 infections are unlikely to benefit from this research.
What this research studies
This research investigates the mechanisms behind acute respiratory distress syndrome (ARDS) caused by COVID-19, focusing on the role of inflammasomes in the excessive release of inflammatory cytokines. By analyzing patient data and conducting experiments with human airway cells, the study aims to uncover how SARS-CoV-2 infection triggers harmful inflammatory responses. The goal is to identify molecular pathways that could be targeted for therapeutic intervention to reduce severe outcomes in COVID-19 patients.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent severe lung inflammation in COVID-19 patients, potentially saving lives.
How similar studies have gone: Previous research has shown that targeting inflammatory pathways can improve outcomes in severe COVID-19 cases, suggesting that this approach may be promising.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Barnett, Katherine Camille — Univ of North Carolina Chapel Hill
- Study coordinator: Barnett, Katherine Camille
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.